Patent ID: 8722023

Claim:
A method of cosmetic treatment for depigmenting the skin by acting on the melanin or the melanocyte, said method comprising selecting as a person in need of such depigmentation a person having lentigo pigmentation spots and/or hyperpigmented melasma lesions on his or her skin, and then administering a composition comprising at least one oxazoline selected from the group consisting of 2-undecyl-4-hydroxymethyl-4-methyl-1,3-oxazoline; 2-undecyl-4,4-dimethyl-1,3-oxazoline; (E)-4,4-dimethyl-2-heptadec-8-enyl-1,3-oxazoline; 4-hydroxymethyl-4-methyl-2-heptadecyl-1,3-oxazoline; (E)-4-hydroxymethyl-4-methyl-2-heptadec-8-enyl-1,3-oxazoline, and 2-undecyl-4-ethyl-4-hydroxymethyl-1,3-oxazoline, as a depigmenting active ingredient, to said person in need thereof, thereby depigmenting said lentigo pigmented spots and/or hyperpigmented melasma lesions.